⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7069443 | 1.00 | — | — | |
| SCHEMBL257234 | 1.00 | — | — | |
| Potassium SCHEMBL30816392 | 0.96 | — | — | |
| SCHEMBL9836842 | 0.96 | — | — | |
| Acetic Acid SCHEMBL733410 | 0.93 | TSHR (0.87) | — | |
| Formic Acid SCHEMBL28114362 | 0.85 | TSHR (0.72) | — | |
| Ethylenediamine SCHEMBL10534337 | 0.85 | NPSR1 (0.72) | — | |
| Butanedione SCHEMBL1424734 | 0.85 | TSHR (0.73) | — | |
| Methacrylic Acid SCHEMBL6307472 | 0.83 | TSHR (0.68) | — | |
| Methacrylic Acid SCHEMBL6307477 | 0.83 | TSHR (0.68) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 386 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011335-A | Self-healing polymer and preparation method and application thereof | 苏州光谨高新材料科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119285502-A | Free radical self-release antifouling agent containing oxime urethane group and preparation method and application thereof | 哈尔滨工程大学 | 2025-01-10 | — | — | CN | claimed |
| US-20240316111-A1 | COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS | VAN DEN BOS, CHRISTIAN (DE) | 2024-09-26 | — | — | US | claimed |
| CN-115109941-B | Method for recovering palladium from palladium-carbon catalyst impregnating solution | 金浦新材料股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-114621284-B | Preparation method of methyldiketone oxime alkoxy silane | 浙江衢州硅宝化工有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117247892-A | Method for changing phagocytic capacity of cells by controlling shear stress | 金凤实验室 | 2023-12-19 | — | — | CN | claimed |
| CN-116789971-A | Preparation method and application of normal-temperature self-healing antifouling resin containing double antifouling factors | 浙江省海洋开发研究院 | 2023-09-22 | — | — | CN | claimed |
| CN-115109941-A | Method for recovering palladium from palladium-carbon catalyst impregnation liquid | 金浦新材料股份有限公司 | 2022-09-27 | — | — | CN | claimed |
| WO-2022148811-A1 | PHARMACEUTICAL COMPOSITION CONTAINING A PARP INHIBITOR AND/OR A GENOTOXIC SUBSTANCE THAT INTERVENES IN THE SYNTHESIS PHASE (S-PHASE) OF CELL REPLICATION, COMBINED WITH AN INHIBITOR OF THE RECQ5 SIGNAL PATH | Technische Universität Darmstadt (DE) | 2022-07-14 | — | — | WO | claimed |
| WO-2020228363-A1 | TWO-COMPONENT LIQUID SILICA GEL FOR 3D PRINTING AND PRINTING METHOD THEREFOR | 华南理工大学 | 2020-11-19 | — | — | WO | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-1014981-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME | Synapse Pharmaceuticals International, Inc. (CA) | 2000-07-05 | — | — | EP | claimed |
| WO-2000003746-A2 | UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY AGENTS THAT DISRUPT ACTIN CYTOSKELETAL ORGANIZATION | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2000-01-27 | — | — | WO | claimed |
| US-5981549-A | Method for controlling or alleviating the symptoms of respiratory disease and allergies | SYNAPSE PHARMACEUTICAL INTERNATIONAL (CA) | 1999-11-09 | — | — | US | claimed |
| US-5916903-A | Method for reducing the effects of antineoplastic disease treatment | SYNAPSE PAHRMACEUTICALS INTERNATIONAL, INC. (CA) | 1999-06-29 | — | — | US | claimed |
| US-5902816-A | Method for treatment of heavy metal poisoning | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1999-05-11 | — | — | US | claimed |
| US-5900418-A | Method for treatment of obesity | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1999-05-04 | — | — | US | claimed |
| US-5824684-A | Method for treating drug and alcohol addiction | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1998-10-20 | — | — | US | claimed |
| WO-1998034615-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYNAPTIC DYSFUNCTION COMPRISING AN OXIME | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1998-08-13 | — | — | WO | claimed |
| US-5760049-A | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use | SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) | 1998-06-02 | — | — | US | claimed |